JANE PERLAS: Open Payments
NPI 1750370904 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 9 payments from 6 companies in 2025. Trend: 2023 $807 · 2024 $869 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $365 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $125 |
| Corcept Therapeutics | 1 | $116 |
| Biogen, Inc. | 1 | $112 |
| Dexcom, Inc. | 2 | $60 |
| Novo Nordisk Inc | 1 | $15 |
Products named: MAVYRET, ANNOVERA, Korlym, ZURZUVAE, Dexcom G6 Transmitter, Wegovy.
Industry payments across CA — which companies pay providers there.
